Search
Publications Icon

Publications

Why do publications about LTFU Study results refer to the Childhood Cancer Survivor Study (CCSS)?

Long-Term Follow-Up Study (LTFU) is the name we use when communicating about the study with participants, while Childhood Cancer Survivor Study (CCSS) is the scientific name used by researchers and the medical community. “Long-Term Follow-Up Study” emphasizes what the study is about without disclosing that some participants may be survivors of childhood cancer, thus protecting their personal health information.

You may hear about the Childhood Cancer Survivor Study or CCSS when important new findings are reported in the news. We want you to take pride in the attention the study receives, because your dedication contributes to every advance we make in protecting the health of survivors.

We're sorry, it looks like there has been an error. Please try again soon.

  • Polygenic risk score improves risk stratification and prediction of subsequent thyroid cancer after childhood cancer.

    2021

    Citation: 30(11):2096-2104

    Author(s): Song N, Liu Q, Wilson CL, Sapkota Y, Ehrhardt MJ, Gibson TM, Morton LM, Chanock SJ, Neglia JP, Arnold MA, Michael JR, Gout AM, Mulder H, Easton J, Bhatia S, Armstrong GT, Zhang J, Delaney A, Hudson MM, Robison LL, Yasui Y, Wang Z.

    Journal: Cancer Epidemiol Biomarkers Prev

  • Impact of the COVID-19 pandemic on a large cohort of adult survivors of childhood cancer.

    2021

    Citation: 68(11):e29324

    Author(s): Krull KR, McDonald A, Goodman P, Vukadinovich C, Ford J, Leisenring WM, Chow E, Robison LL, Armstrong GT.

    Journal: Pediatr Blood Cancer

  • Longitudinal evaluation of neuromuscular dysfunction in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

    2021

    Citation: 30(8):1536-1545

    Author(s): Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS.

    Journal: Cancer Epidemiol Biomarkers Prev

  • Impact of risk-adapted therapy for pediatric Hodgkin Lymphoma on risk of long-term morbidity: a report from the Childhood Cancer Survivor Study.

    2021

    Citation: 39(20):2266-2275

    Author(s): Oeffinger KC, Stratton KL, Hudson MM, Leisenring WM, Henderson TO, Howell RM, Wolden SL, Constine LS, Diller LR, Sklar CA, Nathan PC, Castellino SM, Barnea D, Smith SA, Hutchinson RJ, Armstrong GT, Robison LL.

    Journal: J Clin Oncol

  • Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer.

    2021

    Citation: 30(12):2235-2243

    Author(s): Ghosh T, Chen Y, Dietz AC, Armstrong GT, Howell RM, Smith SA, Mulrooney DA, Turcotte LM, Yuan Y, Yasui Y, Neglia J.

    Journal: Cancer Epidemiol Biomarkers Prev

Related Information